The short answer
Aluminum-containing antacids can markedly lower absorption of oral moxifloxacin. Current tablet instructions require moxifloxacin at least 4 hours before or 8 hours after the aluminum product. A four-hour gap in either direction is incomplete advice.
What this answer covers
Oral moxifloxacin hydrochloride tablets with aluminum-containing antacids or sucralfate. The exposures are distinguished; no gut-absorption result is assigned to injections or eye drops.
- Supplement or preparation
- Aluminum
- Medication ingredient
- moxifloxacin
What did people in the study receive?
In a 12-person crossover study, moxifloxacin taken with an aluminum/magnesium antacid produced about 60% lower total and peak antibiotic exposure. Because that antacid contained both minerals, the reduction cannot be assigned to aluminum alone. A separate sucralfate study also showed substantially lower exposure, but sucralfate is its own aluminum-containing medicine and should be identified by name.
Which dose needs to come first?
For current oral tablets, moxifloxacin should come at least 4 hours before the antacid, or at least 8 hours after it. If the aluminum product is taken first, the longer interval applies. This order is easy to lose in shorthand instructions that say only to separate the products by four hours.
Why does an older paper suggest a shorter interval?
The antacid study tested shorter intervals and observed smaller reductions in overall exposure than with simultaneous dosing. Its authors judged those changes not clinically relevant after considering elimination-adjusted estimates. Current U.S. tablet labeling nevertheless gives the longer 4-hour-before or 8-hour-after instruction. The older interpretation is useful context, not a substitute for today’s product directions.
What should I ask my pharmacist?
Show the exact antacid or sucralfate product, the dose and how often you use it. Repeated stomach-medicine doses can make scheduling more complicated than a single daily supplement. The available studies do not calculate a replacement antibiotic dose after an accidental overlap, so seek advice rather than taking extra moxifloxacin.
Evidence and practical considerations
Absorption & effectiveness
Aluminum-containing antacids can markedly lower absorption of oral moxifloxacin. Current tablet instructions require moxifloxacin at least 4 hours before or 8 hours after the aluminum product. A four-hour gap in either direction is incomplete advice.
- Exact scope
- aluminum-containing oral antacids; sucralfate retained as a distinct related medicine with oral moxifloxacin hydrochloride tablets with strengths expressed as moxifloxacin
- Medication form and route
- oral
- Timing or duration
- Single antibiotic dose with simultaneous and continued antacid or sucralfate dosing.
What remains uncertain
- Healthy-volunteer pharmacokinetics, combined antacid composition and product-specific regimens; older authors favored shorter staggering than current labeling.
Factors that may matter: exact salt and dose; order and interval between doses; other mineral ingredients; oral tablet versus other routes.
Read the supporting source summaries
Source 1: regulatory product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral moxifloxacin tablets.
Directs moxifloxacin at least 4 hours before or 8 hours after the listed products. Reports lower exposure with aluminum/magnesium antacid and ferrous sulfate. Tablet directions also explicitly name zinc.
How this applies: An explicit hydrochloride-to-active-moiety equivalence supports a bounded oral tablet article for parent RxCUI 139462, without merging salt identities or applying gut-absorption findings to injection or ophthalmic use. Article-specific counterparty: aluminum-containing oral antacids; sucralfate retained as a distinct related medicine.
Does not provide a zinc-only clinical trial, or equivalent effect sizes for all magnesium or aluminum salts. Contains no proof that a generic four-hour interval works in both directions.
Source 2: human pharmacokinetic study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Twelve healthy men in the antacid crossover study; a separate 12-person ranitidine study is not the antacid sample.
Simultaneous antacid reduced total and peak exposure by about 60%. Staggered regimens still reduced total exposure by less than 27%; elimination-corrected bioavailability was near control.
How this applies: Direct for the combined aluminum/magnesium antacid with oral moxifloxacin. Current tablet-label timing is used for patient instructions; the older interpretation is not substituted. Article-specific counterparty: aluminum-containing oral antacids; sucralfate retained as a distinct related medicine.
Combined aluminum/magnesium product prevents component attribution. Healthy-volunteer pharmacokinetics only. Authors accepted shorter staggering than current U.S. labeling; this discrepancy is retained. Full clinical paper was not assessed; inspected source is the original author abstract.
Source 3: human pharmacokinetic study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Twelve healthy men aged 21-41 years in a randomized two-way crossover study.
Moxifloxacin relative bioavailability was 40% (90% CI 33-49%) and peak concentration ratio 29%. Absorption was delayed.
How this applies: Related direct aluminum-containing medicinal exposure, explicitly retained as sucralfate rather than merged with aluminum hydroxide. Article-specific counterparty: aluminum-containing oral antacids; sucralfate retained as a distinct related medicine.
Sucralfate is an aluminum-containing medicine, not a generic nutritional aluminum exposure. Repeat sucralfate regimen cannot define every antacid effect. Full clinical paper was not assessed; inspected source is the original author abstract.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Original product guidance and clinical studies checked; complete private article drafted with exact preparation limits and claim dispositions. | |
| Research summary published |
Article revision: 1559c8f31c458eb8
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.